1 / 12

Both Serotonin and Dopamine need to be pushed toward the therapeutic range AND in The Phase 3 Response™

Both Serotonin and Dopamine need to be pushed toward the therapeutic range AND in The Phase 3 Response™. The 3 phase response of Urinary Serotonin and Dopamine. Urinary Neurotransmitters. Are Not Systemic Neurotransmitter Excreted into the Urine.

albert
Download Presentation

Both Serotonin and Dopamine need to be pushed toward the therapeutic range AND in The Phase 3 Response™

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Both Serotonin and Dopamine need to be pushed toward the therapeutic range AND in The Phase 3 Response™

  2. The 3 phase response of Urinary Serotonin and Dopamine

  3. Urinary Neurotransmitters • Are Not Systemic Neurotransmitter Excreted into the Urine Urinary Neurotransmitters are Synthesized by the Kidneys

  4. URINARY MASTER NEUROTRANSMITTERS AND DISEASES URINARY SEROTONIN: In random testing, 7% of people have urinary Serotonin levels above the reference range reported by the lab.

  5. URINARY MASTER NEUROTRANSMITTERS AND DISEASES URINARY SEROTONIN:86.6% of patients not being actively treated with amino acids, but who have been diagnosed with a neurotransmitter disease, have urinary Serotonin levels above the reference range reported by the lab.

  6. URINARY MASTER NEUROTRANSMITTERS AND DISEASES URINARY SEROTONIN: Labs with flawed assay techniques may report that none of the patients have elevated urinary neurotransmitter levels

  7. URINARY MASTER NEUROTRANSMITTERS AND DISEASES Successful treatment depends upon being able to properly identify elevated urinary neurotransmitter levels.

  8. URINARY MASTER NEUROTRANSMITTERS AND DISEASES Urine samples must be collected 5 to 6 hours before bedtime, NOT in the AM.

  9. URINARY MASTER NEUROTRANSMITTERS AND DISEASES Urine samples must be assayed in a lab with the experience and the ability to interpret the assay.

  10. INAPPROPRIATE EXCRETION OF NEUROTRANSMITTERS 94.6% of patients diagnosed with a neurotransmitter disease, not under treatment with amino acids, have inappropriate excretion of one or more neurotransmitters in the lab assays performed prior to treatment.

  11. INAPPROPRIATE EXCRETION OF NEUROTRANSMITTERS Proper use of amino acids corrects the inappropriate excretion of neurotransmitters, as well as provides a relief of disease symptoms.

More Related